Role of a Protein Kinase in Retinal Ganglion Cell Degeneration in Glaucoma
Donald Zack, MD, PhD Wilmer Eye Institute
SummaryThe research proposed in this application will directly determine the potential value of a new protein target in the treatment of vision loss in glaucoma. In addition, Drs. Yang, Zack, and colleagues will evaluate a drug candidate that can block this target for its potential to preserve vision in a rodent model of glaucoma.
The research grant was originally awarded to Zhiyong Yang, M.D., Ph.D. and transferred to Dr. Zack in August of 2013 when Dr. Yang left Johns Hopkins.